Cortes Lacassie syndrome
Cortes Lacassie syndrome is a rare genetic disorder characterized by a combination of distinctive craniofacial abnormalities, skeletal anomalies, and neurological impairments. The syndrome was first described by Cortes and Lacassie in the early 21st century.
Clinical Features[edit]
Individuals with Cortes Lacassie syndrome typically present with a range of clinical features, including:
- Microcephaly (abnormally small head size)
- Facial dysmorphism (distinctive facial features)
- Intellectual disability
- Growth retardation
- Skeletal abnormalities such as scoliosis and joint hypermobility
- Seizures and other neurological impairments
Genetics[edit]
Cortes Lacassie syndrome is believed to follow an autosomal recessive pattern of inheritance. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disorder. The specific gene or genes involved in Cortes Lacassie syndrome have not yet been identified.
Diagnosis[edit]
The diagnosis of Cortes Lacassie syndrome is primarily based on clinical evaluation and the presence of characteristic features. Genetic testing may be used to confirm the diagnosis and to identify the specific genetic mutation responsible for the disorder.
Management[edit]
There is currently no cure for Cortes Lacassie syndrome. Management of the condition is symptomatic and supportive, focusing on improving the quality of life for affected individuals. This may include:
- Physical therapy to address motor skills and mobility issues
- Occupational therapy to assist with daily living activities
- Speech therapy to improve communication skills
- Anticonvulsant medications to manage seizures
- Regular monitoring and treatment of associated medical conditions
Prognosis[edit]
The prognosis for individuals with Cortes Lacassie syndrome varies depending on the severity of the symptoms and the presence of associated medical conditions. Early intervention and supportive care can improve outcomes and enhance the quality of life for affected individuals.
See Also[edit]
References[edit]
External Links[edit]
-
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian